Live Cell Imaging Market By Product (Devices, Consumables, Software), By Technology (Fluorescence Recovery After Photobleaching, Fluorescence Resonance Energy Transfer, High-Content Analysis, Ratiometric Imaging, Fluorescence In Situ Hybridization, Total Internal Reflection Fluorescence Microscopy, Other), By Usage Area (Hospitals And Diagnostic Laboratories, Pharmaceutical And Biotechnology Companies, Other) - Growth, Share, Opportunities & Competitive Analysis, 2017 - 2025

The purpose of this research study titled "Live Cell Imaging Market: Growth, Future Prospects, and Competitive Analysis, 2017–2025" is to provide investors, developers, company executives, and industry participants with in-depth analysis to allow them to take strategic initiatives and decisions related to the prospects in the global live cell imaging market. This report presents and analyses the major trends prevalent in the global live cell imaging market and provides market size and forecast.

This report categorizes the global live cell imaging market in terms of products, technologies, usage areas, and geographical distribution. Based on product types, the global live cell imaging market is categorized into devices (microscopes, standalone systems, image-capturing devices, and cell analyzers), consumables (assays, reagents, kits, media, and other consumables), and software. Fluorescence recovery after photobleaching (FRAP), fluorescence resonance energy transfer (FRET), high-content analysis (HCA), ratiometric imaging, fluorescence in situ hybridization (FISH), total internal reflection fluorescence microscopy (TRIF), multiphoton excitation microscopy (MPE), and others are the chief cell imaging technologies studied in this report. Hospitals and diagnostic laboratories, pharmaceutical, and biotechnology companies, and academic and research institutes are the major usage areas for live cell imaging. The market size and forecast for each mentioned segment for the period 2015–2025 are presented in the report, along with respective CAGRs for the forecast duration of 2017–2025.

Geographically, the global live cell imaging market is best understood by segmenting it into five major regions and five major region-level markets, as follows:

• North America
• U.S.
• Canada
• Europe
• U.K.
• Germany
• France
• Rest of Europe
• Asia Pacific
• Japan
• China
• India
• Rest of Asia Pacific
• Latin America
• Brazil
• Mexico
• rest of Latin America
• Middle East and Africa
• GCC
• Rest of the Middle East and Africa

This study presents the market size and forecast for each considered geographical market for the period 2015-2025, as well as CAGRs for the forecast period 2017-2025, and is further cross-sectionally presented in terms of product, technology, usage area, and constituent region/country level markets.

This report also includes qualitative assessment factors such as market dynamics (drivers, restraints, and opportunities) to have a good understanding of the current and anticipated trends in the global live cell imaging market. Competition assessment tools such as market attractiveness assessment and competitive landscape analysis by key players are also demonstrated in the study. Furthermore, this report concludes with a profile of key market players currently enjoying prominent positions in the live cell imaging market. The key players profiled in this report are ATTO Corporation, BioTek Instruments, Biological Industries, Bio-Rad Laboratories, Becton Dickinson (BD), Essen Bioscience, GE Healthcare, Enzo Life Sciences, Leica Microsystems, Nikon Corporation, Olympus Corporation, PerkinElmer, Thermo Fisher Scientific, and ZEISS International.

The global live cell imaging market is studied for the following product types:

• Devices
• Microscopes
• Standalone Systems
• Image-capturing Devices
• Cell Analyzers
• Consumables
• Assays
• Reagents and Kits
• Media
• Other Consumables
• Software

Live-cell imaging devices currently hold the largest revenue share in the global market. Products such as microscopes, standalone systems, and cell analyzers have always been in high demand across all the fields of pharmaceutical and biotechnology research. The capital costs of imaging devices are the highest among the considered products, along with the respective installation and maintenance expenditures. Furthermore, as new technologies enter the market, there has been a gradual trend in the upgrading and replacement of old imaging devices, resulting in an increase in demand for technologically advanced device systems. On the other hand, consumables such as assays, reagents, kits, and other media and consumables are anticipated to have the largest traded volume in the market. Technological advancement and the introduction of novel kits and assays will majorly determine the market growth of this segment.

The live cell imaging market is studied for the following techniques:

• Fluorescence Recovery After Photobleaching (FRAP)
• Fluorescence Resonance Energy Transfer (FRET)
• High-content Analysis (HCA)
• Ratiometric Imaging
• Fluorescence In Situ Hybridization (FISH)
• Total Internal Reflection Fluorescence Microscopy (TRIF)
• Multiphoton Excitation Microscopy (MPE)
• Other Technologies

Among the considered technologies, fluorescence resonance energy transfer (FRET) accounted for the largest revenue share of the market. Because of the rising prevalence of chronic diseases, increased demand for imaging techniques for determining spatial proximity at the protein level, and the proliferation of related industries such as pharmaceuticals (drug discovery) and biotechnology, the market is expected to grow rapidly during the forecast period. Growth in demand for monoclonal antibodies and rising research and development budgets at pharmaceutical and biotechnology companies will contribute to the growth of this market. Furthermore, the adoption of high-content screening for research purposes in personalized medicine will be the highest in Asia-Pacific markets on the grounds of growing research outsourcing in the region. On the other hand, high costs and a lack of skilled technicians will likely hold back the growth of this market.

Geographically, the global live cell imaging market is cumulative for North America, Europe, Asia Pacific, the Middle East, Africa, and Latin America.

North America currently dominates the global live cell imaging market. The presence of developed pharmaceutical and biotechnology research infrastructure is a major contributor to the region's global dominance. Intensive funding for research and development touting novel drug and biotechnology discoveries in the region is an additional market driver. On the other hand, Asia-Pacific is the fastest-growing market for live cell imaging. R&D initiatives in the region will expand, as will contract research outsourcing to the Asia-Pacific live cell imaging market. Furthermore, the European market will grow primarily as a result of Western Europe's ongoing adoption of cutting-edge life science technologies.

The detailed regional classification of the global live cell imaging market is as follows:

• North America (U.S. and Canada)
• Europe (EU 7, CIS, and Other European Countries)
• Asia-Pacific (China, India, Japan, and the Rest of Asia-Pacific)
• Middle East and Africa (including the Gulf Cooperation Council and the rest of the Middle East and Africa)
• Latin America (Brazil, Mexico, and the Rest of Latin America)

Frequently Asked Questions: